Tuft cells and fibroblasts promote thymus regeneration through ILC2-mediated type 2 immune response.


Journal

Science immunology
ISSN: 2470-9468
Titre abrégé: Sci Immunol
Pays: United States
ID NLM: 101688624

Informations de publication

Date de publication:
12 Jan 2024
Historique:
medline: 12 1 2024
pubmed: 12 1 2024
entrez: 12 1 2024
Statut: ppublish

Résumé

The thymus is a primary lymphoid organ that is essential for the establishment of adaptive immunity through generation of immunocompetent T cells. In response to various stress signals, the thymus undergoes acute but reversible involution. However, the mechanisms governing its recovery are incompletely understood. Here, we used a dexamethasone-induced acute thymic involution mouse model to investigate how thymic hematopoietic cells (excluding T cells) contribute to thymic regeneration. scRNA-seq analysis revealed marked transcriptional and cellular changes in various thymic populations and highlighted thymus-resident innate lymphoid cells type 2 (ILC2) as a key cell type involved in the response to damage. We identified that ILC2 are activated by the alarmins IL-25 and IL-33 produced in response to tissue damage by thymic tuft cells and fibroblasts, respectively. Moreover, using mouse models deficient in either tuft cells and/or IL-33, we found that these alarmins are required for effective thymus regeneration after dexamethasone-induced damage. We also demonstrate that upon their damage-dependent activation, thymic ILC2 produce several effector molecules linked to tissue regeneration, such as amphiregulin and IL-13, which in turn promote thymic epithelial cell differentiation. Collectively, our study elucidates a previously undescribed role for thymic tuft cells and fibroblasts in thymus regeneration through activation of the type 2 immune response.

Identifiants

pubmed: 38215193
doi: 10.1126/sciimmunol.abq6930
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabq6930

Auteurs

Shir Nevo (S)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Noga Frenkel (N)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Noam Kadouri (N)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Tom Gome (T)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
Department of Computer Science and Applied Mathematics, Weizmann Institute of Science, Rehovot, Israel.

Noa Rosenthal (N)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Tal Givony (T)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Ayelet Avin (A)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Cristina Peligero Cruz (C)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.
IrsiCaixa AIDS Research Institute, Hospital Germans Trias i Pujol, Institute for Health Science Research Germans Trias i Pujol (IGTP), Badalona, Spain.

Merav Kedmi (M)

Genomics Unit, Life Science Core Facility, Weizmann Institute of Science, Rehovot, Israel.

Moshit Lindzen (M)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Shifra Ben Dor (S)

Bioinformatics Unit, Life Science Core Facility, Weizmann Institute of Science, Rehovot, Israel.

Golda Damari (G)

Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.

Ziv Porat (Z)

Flow Cytometry Unit, Life Science Core Facility, Weizmann Institute of Science, Rehovot, Israel.

Rebecca Haffner-Krausz (R)

Department of Veterinary Resources, Weizmann Institute of Science, Rehovot, Israel.

Hadas Keren-Shaul (H)

Genomics Unit, Life Science Core Facility, Weizmann Institute of Science, Rehovot, Israel.

Yosef Yarden (Y)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Ariel Munitz (A)

Department of Microbiology and Clinical Immunology, Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel.

Dena Leshkowitz (D)

Bioinformatics Unit, Life Science Core Facility, Weizmann Institute of Science, Rehovot, Israel.

Yael Goldfarb (Y)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Jakub Abramson (J)

Department of Immunology and Regenerative Biology, Weizmann Institute of Science, Rehovot, Israel.

Classifications MeSH